Skip to main content
Caplight Logo









OrganaBio

OrganaBio

Private
Miami, FloridaHealthcare & Life Scienceshttps://www.organabio.com/

Momentum

Top 5%

of companies Caplight tracks

Company Overview

OrganaBio is a biotechnology company that provides ethically sourced biological products, cell processing, and manufacturing services to support cell and gene therapy developers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Pharma Supply Chain, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

CTDMOcell and gene therapyCDMOcellular starting materialscGMP manufacturingcell therapy supply chainleukopaksperipheral blood mononuclear cellsPBMCsclinical cell processingcryopreservation servicescell bankingimmune cellshematopoietic stem cellsHSCsmesenchymal stromal cellsMSCsumbilical cord bloodassay development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OrganaBio Comparables

Compare OrganaBio with similar companies based on industry and business-model similarity.

OrganaBio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CGT Global
80%
Discovery Life Sciences
78%
Theragent
77%

OrganaBio Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 7, 2026

    Open roles increased to 18, 2.2x the trailing average.

  • Jul 20, 2026

    Open roles increased to 12, 43% of headcount.

Recent news

Latest coverage and updates

  • acquiresJul 15, 2026

    OrganaBio, LLC acquired Excellos Labs Inc. on May 1st '26.

  • launchesJul 9, 2026

    OrganaBio, LLC launched time-sensitive PBMC isolation on Jul 9th '26.

  • expands_offices_toJul 9, 2026

    OrganaBio, LLC expanded offices to San Diego, California, United States, Northern America, Americas on Jul 9th '26.

OrganaBio Filings

Explore SEC and related filing metadata, where available.

OrganaBio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about OrganaBio's valuation, stock price, and market status.

Is OrganaBio a public or private company?

OrganaBio is a private company.

What is the current stock price of OrganaBio?

OrganaBio is a private company with no public stock price. No recent secondary market data is available.

How much is OrganaBio worth (valuation)?

Valuation information for OrganaBio is not publicly available.

Can I buy OrganaBio stock?

OrganaBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was OrganaBio's last funding round?

Funding round information for OrganaBio is not publicly available.

Who are the main investors in OrganaBio?

Investor information for OrganaBio is not publicly disclosed.

Will OrganaBio IPO soon?

No public IPO plans have been announced for OrganaBio.

How can I track OrganaBio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OrganaBio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMiami, Florida
Employee Range24
Year Founded2018
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?